Thomas Holden focuses his practice on representing public companies, private investment funds, investment banks and universities in public offerings, private financings and business combinations. In addition, Thomas counsels public company and hedge fund clients on a wide range of securities law compliance and governance issues.
His clients have included Bain Capital, TPG, Silver Lake Partners, Canada Goose, Blue Coat Systems, Petco, Jones Snowboards, Wright Medical Group, Novavax, Ironwood Pharmaceuticals, Pfizer, Putnam Investments, Dragoneer, Stanford University, Harvard Management Company and many of the world’s leading investment banks.
- JD, cum laude, Boston College Law School, 2005
- BA, summa cum laude, University of Massachusetts Amherst, 1999
- California, 2015
- Massachusetts, 2005
MEMBERSHIP & AFFILIATIONS : Law360 Capital Markets Editorial Advisory Board (2016)
- Represented the underwriters in connection with securities offerings valued in the billions of dollars, including for the following companies:
- Wayfair, one of the world’s largest online destinations for the home
- Care.com, the world’s largest online marketplace for finding and managing family care
- Numerous other common stock and convertible note offerings, including A123 Systems, American Superconductor, Tranzyme, Lexicon Pharmaceuticals, LogMeIn, Idenix Pharmaceuticals, Biodel, Micromet and Regeneron Pharmaceuticals.
- Blue Coat Systems., a provider of Web security solutions for enterprises and governments worldwide, in its IPO which concluded with its $4.65 billion sale to Symantec Systems.
- Petco Holdings, a leading specialty retailer of pet food, supplies, services and companion animals backed by TPG Capital and Leonard Green Partners, in its proposed IPO and subsequent $4.6 billion sale to CVC Capital Partners and Canada Pension Plan Investment Board.
- Taylor Morrison, one of the largest public homebuilders in North America, in its $600 million initial public offering. (Up-C Structure) and subsequent follow-on offerings worth $397.8 million total.
- Covidien plc, a leading global provider of health care products, in its acquisition of Maya Medical, a developer of a treatment for hypertension, for an upfront cash payment of $60 million and up to an additional $170 million in contingent consideration.
- AccessClosure, Inc., a leading manufacturer and distributor of extravascular closure devices in the United States, in its $320 million sale to Cardinal Health.
Rate : $$$